Targeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context

Abdulhaq H, Hwang A, Mahmood O

OncoTargets and Therapy 2023, 16:617-629

Published Date: 20 July 2023